A new study published in The Lancet raises concerns about the potential transmission of amyloid β pathology through blood transfusions. The research suggests that proteins associated with Alzheimer's disease could be transferred to recipients, leading to the development of amyloid deposits in the brain. The study analyzed data from individuals who received blood products from donors later diagnosed with Alzheimer's disease, finding a correlation between transfusion and subsequent amyloid accumulation.

The findings challenge previous assumptions about the exclusively genetic or age-related nature of amyloid pathology. While the absolute risk remains low, the implications for blood banking and transfusion practices could be significant. The authors emphasize the need for further research to confirm these observations and understand the mechanisms involved.

Currently, there are no changes recommended for blood donation protocols. However, the study highlights the importance of continued surveillance and investigation into the potential for protein misfolding diseases to be transmitted through medical procedures. The research opens new avenues for understanding the spread of neurodegenerative conditions.